Search for: "Janssen Pharmaceutical Research " Results 1 - 20 of 115
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
13 Oct 2020, 12:00 am by D Daniel Sokol
Switching Costs, Brand Premia and Behavioral Pricing in the Pharmaceutical Market Aljoscha Janssen Singapore Management University; Research Institute of Industrial Economics (IFN) Date Written: May 20, 2020 Abstract This article examines the market power of branded prescription drugs faced with... [read post]
18 Sep 2020, 8:45 am by D Daniel Sokol
Switching Costs, Brand Premia and Behavioral Pricing in the Pharmaceutical Market Aljoscha Janssen Singapore Management University; Research Institute of Industrial Economics (IFN) Abstract This article examines the market power of branded prescription drugs faced with generic competition. [read post]
18 Sep 2020, 12:00 am by D Daniel Sokol
Price Dynamics of Swedish Pharmaceuticals Aljoscha Janssen Singapore Management University; Research Institute of Industrial Economics (IFN) Abstract This paper investigates price patterns of off-patent pharmaceuticals in Sweden. [read post]
22 Dec 2015, 6:39 am by Daily Record Staff
Intrexon will work with Janssen Pharmaceutica NV, one of the Janssen pharmaceutical companies of Johnson & Johnson, to discover and develop Intrexon’s ActoBiotics therapies to treat type 2 diabetes, ... [read post]
6 Apr 2015, 6:27 pm by Altman & Altman
According to a state superior court, the parents of a child who sustained serious birth defects because the mother took Topamax while she was pregnant is entitled to $11.6 million from Johnson & Johnson’s Janssen Pharmaceuticals. [read post]
1 Nov 2015, 9:57 pm by Patent Docs
Par Pharmaceutical Inc. et al. 1:15-cv-00679; filed August 3, 2015 in the District Court of Delaware • Plaintiffs: Janssen Biotech Inc.; Janssen Oncology Inc.; Janssen Research & Development LLC • Defendants: Amneal Pharmaceuticals LLC; Amneal Pharmaceuticals of New York LLC; Par Pharmaceutical Inc.; Par Pharmaceutical Companies Inc. [read post]
1 Apr 2024, 10:58 am by Dennis Crouch
by Dennis Crouch In April 2024, the Federal Circuit issued a significant decision vacating a district court’s judgment that Janssen Pharmaceuticals’ dosing regimen patent claims were nonobvious. [read post]
3 Aug 2012, 12:27 pm by Morse, Barnes-Brown Pendleton
On July 10th it was announced that MBBP client Harvard University, has entered into an agreement with Johnson & Johnson subsidiary Janssen Pharmaceuticals and Evotec, a German biotechnology company. [read post]
30 Dec 2016, 6:28 am by Law Offices of Jeffrey S. Glassman
  Janssen Research and Development was formerly known as Johnson and Johnson Pharmaceuticals Research and is still a wholly owned subsidiary of the pharmaceutical giant. [read post]
18 Nov 2020, 11:19 am by Ronald V. Miller, Jr.
Elmiron is the brand name of a popular prescription drug manufactured by Janssen Pharmaceuticals. [read post]
14 Jan 2015, 4:34 pm by Sabrina I. Pacifici
External researchers can make a request for clinical trial data on products from Janssen, the pharmaceutical companies of Johnson & Johnson, using the following link: www.clinicaltrialstudytransparency.com. [read post]
2 Dec 2013, 9:11 am by Breakstone, White & Gluck
Janssen Pharmaceuticals, a unit of Johnson & Johnson, has been ordered to pay $11 million to a mother who was prescribed Topomax and gave birth to a son with a cleft lip. [read post]
4 May 2017, 1:00 am by Jiao Yuxin
The clinical research of pharmaceutical polymorphs commenced in 1950s internationally though, it was until in mid-1990s did Chinese research institutions and pharmaceutical enterprises recognize the importance of pharmaceutical polymorphs after the first awareness of the significant efficacy difference between imported nimodipine and the homemade one. [read post]
3 Sep 2021, 9:27 am by Ronald V. Miller, Jr.
As a result, hundreds of people have filed Elmiron lawsuits against Johnson & Johnson and their pharmaceutical subsidiary, Janssen, alleging that the company’s bladder drug Elmiron caused them to suffer from vision loss. [read post]
4 Oct 2010, 3:51 am by Bob Kraft
" The "case centers on drug safety claims that J&J and its Ortho-McNeil-Janssen Pharmaceutical unit made in November 2003 correspondence to 700,000 doctors. [read post]
2 Sep 2020, 1:45 pm by Tom Lamb
JOHNSON & JOHNSON d/b/a Alza Corporation, d/b/a Janssen Ortho LLC, d/b/a Janssen Research & Development LLC, d/b/a Ortho-McNeil Pharmaceuticals, Inc. [read post]
3 Sep 2020, 5:03 am by Apsosredesign
  Pisco pressed charges against Janssen Pharmaceuticals. [read post]
4 Oct 2010, 9:48 am by Bob Kraft
” The “case centers on drug safety claims that J&J and its Ortho-McNeil-Janssen Pharmaceutical unit made in November 2003 correspondence to 700,000 doctors. [read post]
4 Nov 2013, 9:56 pm by Jon Gelman
Under the FDCA, a pharmaceutical company must specify the intended uses of a drug in its new drug application to the FDA. [read post]